{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:59:56Z","timestamp":1791583196154,"version":"4.3.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s00405-022-07634-x","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T13:06:58Z","timestamp":1663074418000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparison of guidelines for prescription and follow-up of biologics for chronic rhinosinusitis with nasal polyps"],"prefix":"10.1007","volume":"280","author":[{"given":"Andrea","family":"Rampi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Vinciguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Tanzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Bussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6472-3484","authenticated-orcid":false,"given":"Matteo","family":"Trimarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,13]]},"reference":[{"issue":"Suppl S29","key":"7634_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4193\/Rhin20.600","volume":"58","author":"WJ Fokkens","year":"2020","unstructured":"Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58(Suppl S29):1\u2013464. https:\/\/doi.org\/10.4193\/Rhin20.600","journal-title":"Rhinology"},{"key":"7634_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/ALR.22741","volume":"11","author":"RR Orlandi","year":"2021","unstructured":"Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU et al (2021) International consensus statement on allergy and rhinology: rhinosinusitis. Int Forum Allergy Rhinol 11:213\u2013739. https:\/\/doi.org\/10.1002\/ALR.22741","journal-title":"Int Forum Allergy Rhinol"},{"key":"7634_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/JAMAOTO.2015.3142","volume":"142","author":"JC Ahn","year":"2016","unstructured":"Ahn JC, Kim JW, Lee CH, Rhee CS (2016) Prevalence and risk factors of chronic rhinosinusitus, allergic rhinitis, and nasal septal deviation: results of the Korean National Health and Nutrition Survey 2008\u20132012. JAMA Otolaryngol Head Neck Surg 142:162\u2013167. https:\/\/doi.org\/10.1001\/JAMAOTO.2015.3142","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"7634_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1177\/000348940311200709","volume":"112","author":"L Johansson","year":"2003","unstructured":"Johansson L, \u00c5kerlund A, Holmberg K, Mel\u00e9n I, Bende M (2003) Prevalence of nasal polyps in adults: the Sk\u00f6vde population-based study. Ann Otol Rhinol Laryngol 112:625\u2013629. https:\/\/doi.org\/10.1177\/000348940311200709","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"7634_CR5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/alr.22487","volume":"10","author":"CA Loftus","year":"2020","unstructured":"Loftus CA, Soler ZM, Koochakzadeh S, Desiato VM, Yoo F, Nguyen SA et al (2020) Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors. Int Forum Allergy Rhinol 10:199\u2013207. https:\/\/doi.org\/10.1002\/alr.22487","journal-title":"Int Forum Allergy Rhinol"},{"key":"7634_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12948-015-0026-8","volume":"13","author":"M-R Yacoub","year":"2015","unstructured":"Yacoub M-R, Trimarchi M, Cremona G, Dal Farra S, Ramirez GA, Canti V et al (2015) Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps? Clin Mol Allergy y 13:23. https:\/\/doi.org\/10.1186\/s12948-015-0026-8","journal-title":"Clin Mol Allergy y"},{"key":"7634_CR7","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/ccr3.3792","volume":"9","author":"M Trimarchi","year":"2021","unstructured":"Trimarchi M, Indelicato P, Vinciguerra A, Bussi M (2021) Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial. Clin Case Rep 9:1428\u20131432. https:\/\/doi.org\/10.1002\/ccr3.3792","journal-title":"Clin Case Rep"},{"key":"7634_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14639\/0392-100X-N1614","volume":"42","author":"E de Corso","year":"2022","unstructured":"de Corso E, Bellocchi G, de Benedetto M, Lombardo N, Macchi A, Malvezzi L et al (2022) Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the Joint Committee of Italian Society of Otorhinolaryngology on biologics in rhinology. Acta Otorhinolaryngol Ital 42:1\u201316. https:\/\/doi.org\/10.14639\/0392-100X-N1614","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"7634_CR9","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","volume":"394","author":"C Bachert","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE et al (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet 394:1638\u20131650. https:\/\/doi.org\/10.1016\/S0140-6736(19)31881-1","journal-title":"Lancet"},{"key":"7634_CR10","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","volume":"146","author":"P Gevaert","year":"2020","unstructured":"Gevaert P, Omachi TA, Corren J, Mullol J, Han J, Lee SE et al (2020) Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immunol 146:595\u2013605. https:\/\/doi.org\/10.1016\/j.jaci.2020.05.032","journal-title":"J Allergy Clin Immunol"},{"key":"7634_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00405-022-07389-5","volume":"1","author":"A Vinciguerra","year":"2022","unstructured":"Vinciguerra A, Rampi A, Yacoub M-R, Tresoldi M, Tanzini U, Bussi M et al (2022) Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary results. Eur Arch Otorhinolaryngol 1:1\u20138. https:\/\/doi.org\/10.1007\/s00405-022-07389-5","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"7634_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/J.BJORL.2021.03.003","author":"WT Anselmo-Lima","year":"2021","unstructured":"Anselmo-Lima WT, Tamashiro E, Romano FR, Miyake MM, Roithmann R, Kosugi EM et al (2021) Guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps (CRSwNP) in Brazil. Braz J Otorhinolaryngol. https:\/\/doi.org\/10.1016\/J.BJORL.2021.03.003","journal-title":"Braz J Otorhinolaryngol"},{"key":"7634_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/S40463-021-00493-2","author":"A Thamboo","year":"2021","unstructured":"Thamboo A, Kilty S, Witterick I, Chan Y, Chin CJ, Janjua A et al (2021) Canadian Rhinology Working Group consensus statement: biologic therapies for chronic rhinosinusitis. J Otolaryngol Head Neck Surg. https:\/\/doi.org\/10.1186\/S40463-021-00493-2","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"5","key":"7634_CR14","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1111\/coa.13779","volume":"46","author":"C Hopkins","year":"2021","unstructured":"Hopkins C, McKenzie JL, Anari S, Carrie S, Ramakrishnan Y, Kara N et al (2021) British Rhinological Society Consensus Guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps. Clin Otolaryngol 46(5):1037\u20131043. https:\/\/doi.org\/10.1111\/coa.13779","journal-title":"Clin Otolaryngol"},{"issue":"12","key":"7634_CR15","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1111\/all.13875","volume":"74","author":"WJ Fokkens","year":"2019","unstructured":"Fokkens WJ, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J et al (2019) EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy 74(12):2312\u20132319. https:\/\/doi.org\/10.1111\/all.13875","journal-title":"Allergy"},{"issue":"1","key":"7634_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaci.2020.11.013","volume":"147","author":"C Bachert","year":"2021","unstructured":"Bachert C, Han JK, Wagenmann M, Hosemann W, Lee SE, Backer V et al (2021) EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol 147(1):29\u201336. https:\/\/doi.org\/10.1016\/j.jaci.2020.11.013","journal-title":"J Allergy Clin Immunol"},{"key":"7634_CR17","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S321017","author":"M Al-Ahmad","year":"2022","unstructured":"Al-Ahmad M, Alsaleh S, Al-Reefy H, Al Abduwani J, Nasr I, Al Abri R et al (2022) Expert opinion on biological treatment of chronic rhinosinusitis with nasal polyps in the Gulf Region. J Asthma Allergy. https:\/\/doi.org\/10.2147\/JAA.S321017","journal-title":"J Asthma Allergy"},{"key":"7634_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.waojou.2021.100592","volume":"14","author":"C Lombardi","year":"2021","unstructured":"Lombardi C, Asero R, Bagnasco D, Blasi F, Bonini M, Bussi M et al (2021) ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments. World Allergy Organ J 14:100592. https:\/\/doi.org\/10.1016\/j.waojou.2021.100592","journal-title":"World Allergy Organ J"},{"key":"7634_CR19","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1002\/lary.28648","volume":"131","author":"GA Scangas","year":"2021","unstructured":"Scangas GA, Wu AW, Ting JY, Metson R, Walgama E, Shrime MG et al (2021) Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps. Laryngoscope 131:E26-33. https:\/\/doi.org\/10.1002\/lary.28648","journal-title":"Laryngoscope"},{"key":"7634_CR20","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.2147\/DDDT.S226575","volume":"14","author":"HH Kariyawasam","year":"2020","unstructured":"Kariyawasam HH, James LK (2020) Chronic rhinosinusitis with nasal polyps: targeting IgE with anti-IgE omalizumab therapy. Drug Des Dev Ther 14:5483\u20135494. https:\/\/doi.org\/10.2147\/DDDT.S226575","journal-title":"Drug Des Dev Ther"},{"key":"7634_CR21","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/nejmoa1804093","volume":"378","author":"KF Rabe","year":"2018","unstructured":"Rabe KF, Nair P, Brusselle G, Maspero JF, Castro M, Sher L et al (2018) Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Eng J Med 378:2475\u20132485. https:\/\/doi.org\/10.1056\/nejmoa1804093","journal-title":"N Eng J Med"},{"key":"7634_CR22","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","volume":"137","author":"P Tomassen","year":"2016","unstructured":"Tomassen P, Vandeplas G, van Zele T, Cardell LO, Arebro J, Olze H et al (2016) Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol 137:1449-1456.e4. https:\/\/doi.org\/10.1016\/j.jaci.2015.12.1324","journal-title":"J Allergy Clin Immunol"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-022-07634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-022-07634-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-022-07634-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T01:07:37Z","timestamp":1673140057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-022-07634-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["7634"],"URL":"https:\/\/doi.org\/10.1007\/s00405-022-07634-x","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,13]]},"assertion":[{"value":"30 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None of the authors have any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}